KATE DOLEZAL: Open Payments
NPI 1225613862 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 12 payments from 8 companies in 2025. Trend: 2023 $417 · 2024 $319 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $106 |
| Cleerly, Inc. | 1 | $71 |
| Lilly USA, LLC | 3 | $59 |
| Bioventus LLC | 1 | $35 |
| Lundbeck LLC | 1 | $21 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
| Phadia US Inc. | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: DUPIXENT, Cleerly Ischemia, MOUNJARO, XCELL, VYEPTI, NP Thyroid 60, ImmunoCAP, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
